Alejandro Dorenbaum
Technik-/Wissenschafts-/F&E-Leiter bei RENEO PHARMACEUTICALS, INC.
Vermögen: - $ am 30.06.2024
Aktive Positionen von Alejandro Dorenbaum
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - | - |
Karriereverlauf von Alejandro Dorenbaum
Ehemalige bekannte Positionen von Alejandro Dorenbaum
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2014 | 01.06.2017 |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2013 | 30.06.2014 |
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01.01.2003 | 01.01.2003 |
| The University of California, San Francisco | Corporate Officer/Principal | 01.01.2000 | 01.01.2000 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | - |
Ausbildung von Alejandro Dorenbaum
| Universidad Nacional Autónoma de México | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Mexiko | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ALLAKOS INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- Alejandro Dorenbaum
- Erfahrung
